Skip to content

Homoeopathic medicinal effect on knee pain.

Efficacy Of Individualized homoeopathic medicines in treatment of knee Osteoarthritis:Evaluation By Double-Blind ,Randomized,Placebo-Controlled Trial

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025146
Enrollment
72
Registered
2020-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Homoeopathic individualized medicine in centesimal Potency.: -Experimental arm:Intervention is planned as administering indicated homoeopathic medicines centesimal potencies ,as decided
dosage and repetition depending upon the individual requirement of the cases.All medicines will be procured from a Good Manufacturing Practice(GMP)-certified firm.General management will include ice c
dosage and repetition depending upon the individual requirement of the cases .Management guidelines will be given as in the experimental arm.Duration of therapy:3 months. Control Intervention2: Placeb
dosage and repetition depending upon the individual requirement of the cases .Management guidelines will be given as in the experimental arm.Duration of therapy:3 months.

Sponsors

State National homoeopathic Medical College and Hoapital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Diagnosed knee osteoarthritis as per American College of Rheumatology (ACR)clinical/radiographic classification criteria,(sensitivity91%,specificity86%): -knee pain -At least 1 of 3:age more than 50yrs,stiffness less than 30min,and crepitus on knee motion -Osteophytes on knee x-ray 2)Patients already undergoing regular oral or topical analgesics or NSAID therapy for painful episodes of osteoarthritis ,provided the medications are stopped completely at least 2 weeks prior study entry 3)Literate patients;can read Hindi or English 4)Providing written informed consent

Exclusion criteria

Exclusion criteria: 1)Severe degeneration of knee joint with marked joint narrowing ,varus,or valgus deformity of knee ( >12degree),evedenced by imaging or otherevidences and requiring surgical intervention 2)Non-ambulant patients 3)Self -reported joint disorders other than osteoarthritis 4)Intra-articular injections within 2weeks before study entry 5)Transplanted kness 6)Recent significant knee surgeory within last 6 months 7)Patients who are too sick for consultation 8)Unwilling to take part and not giving consent to join the study 9)Unable to read patient information sheet 10)Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life 11)Pregnancy and lactation 12)Substance abuse and/or dependence 13)Self-reported immune-compromised state 14)Undergoing homoeopathic treatment for any chronic disease within last 6 months.

Design outcomes

Primary

MeasureTime frame
Knee injury and osteoarthritis outcome score(KOOS)Timepoint: Baseline ,every month upto 3rd month

Secondary

MeasureTime frame
European quality of life -five dimension -five level scoring(EQ-5D-5L)Timepoint: Baseline,every month upto 3rd month;Frequency of add-on Paracetamol or NSAIDsTimepoint: Baseline,every month upto 3rd month

Countries

India

Contacts

Public ContactDr arvind kumar verma

State national medical college and hospital

arvindkr.verma@gov.in7275809725

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026